Ewa Wasilewski

This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Cannscience Innovations Inc., University Health Network. Active years: 2018-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ewa Wasilewski. Retrieved from https://idiyas.com/inventor/ewa-wasilewski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 4 (Patent Applications = 2)

% Patents Active = 25.0

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 21(Granted Patents)

Company Filing History:

3 out of 3

Cannscience Innovations Inc.

patents

1 out of 312

University Health Network

patents

Years Active: 2018-2020

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10716791 - Inhibitors of peptidyl arginine deiminase (PAD) enzymes and uses thereof (2020-07-21),

2. 10537592 - Decarboxylated cannabis resins, uses thereof and methods of making same (2020-01-21),

3. 10383892 - Decarboxylated cannabis resins, uses thereof and methods of making same (2019-08-20),

4. 10143706 - Decarboxylated cannabis resins, uses thereof and methods of making same (2018-12-04),

Title: Ewa Wasilewski: Innovator in Biochemistry and Cannabis Research

Introduction

Ewa Wasilewski is a prominent inventor based in Etobicoke, Canada. She has made significant contributions to the fields of biochemistry and cannabis research. With a total of 4 patents to her name, her work focuses on innovative solutions for medical applications.

Latest Patents

Wasilewski's latest patents include groundbreaking research on inhibitors of peptidyl arginine deiminase (PAD) enzymes. This application relates to a-substituted amino acid compounds and their use in treating diseases associated with hypercitrullination of proteins. Another notable patent involves decarboxylated cannabis resins, detailing methods for their extraction and use in pharmaceutical products. These advancements highlight her commitment to addressing complex medical challenges.

Career Highlights

Throughout her career, Ewa Wasilewski has worked with notable organizations such as Cannscience Innovations Inc. and the University Health Network. Her experience in these institutions has allowed her to develop and refine her innovative ideas, contributing to the advancement of medical science.

Collaborations

Wasilewski has collaborated with talented individuals in her field, including Lakshmi Premakanth Kotra and Melissa Maureen Lewis. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Ewa Wasilewski's contributions to biochemistry and cannabis research exemplify her dedication to innovation. Her patents and collaborations reflect her impact on the scientific community and her commitment to improving health outcomes.

Profile summary based on public USPTO records.